Navigation Links
Reliability and benefit of diagnostic procedure for asthma in young children is unclear
Date:8/20/2009

t strategy consisting of a test and an intervention.

If information on diagnostic procedures and therapeutic measures is only available in separate studies (Phase 2 and 3 diagnostic studies, and therapy studies), it is possible to try to synthesize and link them to a certain extent. In this way, at least indirect findings on the clinical efficacy of diagnostic procedures can be obtained. However, this method of "linked evidence" involves certain methodological requirements. As IQWiG and its external experts established, the studies available to date on diagnosing asthma in children under 5 years of age do not contain these requirements. Thus, a reference standard was particularly lacking.

No robust conclusions concerning efficacy possible

Even a modified procedure which, based on the linked evidence criteria, attempts to link the studies without a reference test is not possible. This is in part because the asthma-specific selection criteria are not precisely described in the therapy studies. Furthermore, none of the therapy studies used a selection method whose diagnostic accuracy had already been proven by studies.

IQWiG has therefore concluded that the results from the diagnostic and therapy studies cannot actually be synthesized in terms of "linked evidence". No robust conclusions can be drawn concerning the accuracy of individual tests used in therapy studies nor on the clinical efficacy of interventions tested in Phase 2 and 3 diagnosis studies.

Report preparation stage

IQWiG published the preliminary results in two separate preliminary reports in June (Part 1) and in September (Part 2) 2008 and interested parties were invited to submit comments. When the comments stage ended, the two preliminary reports were revised and then compiled into a final report, which was sent to the contracting agency at the beginning of June 2009. Documentation of the written comments for both preliminary reports an
'/>"/>

Contact: Dr. Anna-Sabine Ernst
info@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Study examines reliability of clinical and pathological diagnoses of Barretts esophagus
2. Study tests reliability of more accurate measure of patient pain
3. Study suggests reliability of cognitive assessment tool varies widely
4. Reliability & Confidence Define a Nation Of It Girls
5. Miami-Area Experienced Fewer Fluctuations in Pharmacy Benefit Enrollment Than Other Florida Markets
6. Palliative care intervention for patients with advanced cancer provides quality of life benefits
7. Retirees health-care benefits at risk, study warns
8. Chemo Plus Palliative Care Reaps Benefits
9. CA$H-First(SM) LTCi Provides First-Day Cash Benefits at Affordable Rates
10. Free Online Tools Benefitting Time-Starved, Cost-Conscious Home Cooks
11. Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...PRNewswire-USNewswire/ -- The American Academy of...care reform legislation released this week to cont... individual coverage mandate. The actuaries said t...mize adverse selection stemming from more restrict... ,, "The individual mandate language should be ...
(Date:11/20/2009)... Following a recall by Unilever The...sale Shedd,s Country Crock ® Side Dishes DELU... ® Side Dishes DELUXE Four Cheese Pasta due t...wing code dates and UPCs are affected: ,, Shed...r Broccoli Rice 21 oz, UPC 027400218316, Best By N...
(Date:11/20/2009)...20 Rates of infection by...late October, but the pandemic flu virus continues...oups, including the elderly, according to a new re...X ), the world,s leading provider of diagnostic te...t recent Quest Diagnostics Health Trends(TM) Repor...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Centene Corporation (NY...t the Bank of America Merrill Lynch 2009 Credit Co...owne Plaza Hotel Times Square in New York City. ,...t 8:30 a.m. Eastern Time. Investors and other inte... Centene,s presentation at: http://www.veracast.c...
(Date:11/20/2009)...v. 20 Samuel Gladding i...hat it means to be "happy" during the holidays. As...y in family counseling and chair of the Department... says research shows that it is the pressure to be...sion during the holidays. ,, That,s why he,s ch...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2
... an examination hall and scratching ones head migh...he hour would be to move your eyes from side to si...s in an examination sitting, but it might be the o...end to the other for 30 seconds every morning. Thi...
...vulsive therapy (ECT) helps patients with severe d...nd should be considered more often in the earlier ... the Southern Medical Journal. "Electrocon...and schizophrenia," writes Dr. Stephen Taylor of t...
...utbreak of disease has claimed a tenth of Idahos t... fish food and labor. The outbreak of Ichthy...out from a hatchery in southwestern Idaho- the sta...ss from overcrowding weakened the fish, making the...
...s separatist outfit, Dukhtaran-e-Milat (DeM) Monda... schools despite officials having no such plans. ...Andrabi, the DeM chief said, "We shall oppose toot... Andrabi, branded as a hardliner, said sex wa...
...ng a State subject, the data in regard to doctor-p... is not maintained centrally. The doctor-patient ...ious factors like the type of disease, nature of s... present works out to 1:1722. The patient...
...tts-based company Advanced Cell Technology, is o... hemangioblasts or stem cells that repair arterie...pany,the stem cells made from human embryos can p...ssel precursor cells out of the stem cells. The co...
Other Medicine News:Health News:Eyeing a Good Memory - Not an Exercise in Futility! 2Health News:Despite Being Effective Electroconvulsive Therapy is Underused for Severe Depression 2Health News:Disease Outbreak Claims Trout From Idaho Hatchery 2Health News:Hemangioblasts Aiding Eye Damage Repair 2
(Date:11/20/2009)... YORK, Nov. 20 Reportlinker.com an...able in its catalogue. ,, Global Self Monitori...n to Drive Growth ,, http://www.reportlinker...-Market-(SMBG )-Increasing-Adoption-to-Drive-Growt...;utm_campaign=prnewswire ,, Description ,...
(Date:11/20/2009)... YORK, Nov. 20 Reportlinker.com an...able in its catalogue. ,, Global Markets for A...www.reportlinker.com/p0164742/Global-Markets-for-A...prnewswire&utm_medium=pr&utm_campaign=prne...ction covers the U.S., 15 Countries in Europe and ...
(Date:11/20/2009)...ON, Nov. 20 Cyberonics, ...re, President and Chief Executive Officer, and Gre... the 21st Annual Piper Jaffray Health Care Confere...12:00 PM EST. The conference session and webcast ...esented. Piper Jaffray will host a webcast of the...
Breaking Medicine Technology:Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Summit Health Helps Employers Navigate the Wild West of Flu Shots and Workplace Health Screenings 56603 1Summit Health Helps Employers Navigate the Wild West of Flu Shots and Workplace Health Screenings 56603 2American Airlines Employees Raise 241 Million for American Cancer Society 56600 1American Airlines Employees Raise 241 Million for American Cancer Society 56600 2American Airlines Employees Raise 241 Million for American Cancer Society 56600 3Exotic Adventure and Clean Food 3A The Adventure Cookbook 56597 1Exotic Adventure and Clean Food 3A The Adventure Cookbook 56597 2
...3, 2007 /PRNewswire/ -- Southern,Research Institut...ic and applied research in the areas of preclinica...ced that its scientists,will be delivering one ora...2007 American Association for Cancer Research,(AAC...if. , Anshu Mittal Roy of Southern Research will b...
...007 /PRNewswire-FirstCall/ -- Celgene,Corporation ...oup,(ECOG) has reported that its Data Monitoring C...m a large, randomized clinical,trial for patients ...at the use of a low dose of dexamethasone (Decadro...val advantage for,patients when compared to the hi...
Other Medicine Technology:Southern Research Institute to Present at the 2007 American,Association For Cancer Research Annual Meeting 2Southern Research Institute to Present at the 2007 American,Association For Cancer Research Annual Meeting 3ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 2ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 3ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 4ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 5ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 7
Thermomat Patient Warming System
COCOON Convective Warming System CWS 4000
Equator™ Convective Warmer
QuickVue Advance® G. vaginalis test.
Medicine Products: